https://www.ajmc.com/view/which-chemo-io-combo-is-optimal-in-first-line-esophageal-cancer-
0
0
9/2/22 at 1:23pm
Organization
Ajmc.com
Author
Jaime Rosenberg
41 words
0
Comments
The review of 5 phase 3 randomized controlled trials found that overall, the combination treatments improved survival outcomes while eliciting more, but manageable, side effects.
You are the first to view
Create an account
or login to join the discussion